Leading Pharmaceutical and Biopharmaceutical Company | Pfizer

 

News

Important Update on EpiPen® (epinephrine injection, USP) 0.3 mg Auto-Injectors

Extended Expiration Dates for Select Lots of EpiPen® 0.3 mg Auto-Injectors and Its Authorized Generic

View the update
Our Science

When Routine Surgeries Turn Dangerous

With the global rise of antimicrobial resistance, scientists are pursuing vaccines as a way to help prevent bacterial infections.

Learn more about vaccines currently being developed
Your Health

Addressing the Unique Health Needs of African Americans

The African American Health Engagement Study examines the health attitudes and behaviors of African Americans.

Read The Study Findings
Your Health

Sickle Cell Awareness Month

Clinical Trials can help introduce much needed therapies.

See How You Can Help

Find a Trial

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your zip code, city, or country to find studies near you.
Advanced Search
Our Science

Two Promising Neuroscience Startups Awarded “Golden Tickets”

In June 2018, Pfizer Kendall Square opened a call for interested U.S. startup companies focused on neuroscience to submit non-confidential proposals for a Pfizer-sponsored LabCentral “Golden Ticket.”

Learn More
Your Health

5 Facts About Real-World Data

Real-World Data (RWD) can help us further understand the effectiveness, safety and costs associated with a treatment option, potentially offering complementary insights to clinical trial findings.

See The 5 Facts Of RWD
Latest news
Pfizer Granted FDA Breakthrough Therapy...

Pfizer Inc. (NYSE:PFE) announced today that its 20-Valent Pneumococcal Conjugate Vaccine (20vPnC) candidate, PF-06482077, received Breakthrough Therapy designation from the US Food and Drug Administration (FDA) for the prevention of invasive disease and pneumonia caused by...

Read more